Big fine for Nurofen in Australia over misleading claims

December 16, 2016

Drug giant Reckitt Benckiser was slapped with a Aus$6 million (US$4.4 million) fine Friday for making misleading claims about its popular Nurofen Specific Pain brand in Australia.

The country's consumer watchdog took action against the company in 2015, disputing Nurofen packaging claims that products in the range were formulated to treat different types of , when the was identical.

The Federal Court last year ruled the British-based multinational engaged in deceptive conduct between 2011 and 2015 with the main ingredient, ibuprofen lysine, the same in all the products with none better at treating one type of pain than others.

It fined the group Aus$1.7 million, but the Australian Competition and Consumer Commission (ACCC) appealed, claiming it was inadequate and did not serve as an effective deterrent.

The court Friday revised the penalty to Aus$6 million "to ensure that Reckitt Benckiser and other 'would-be wrongdoers' think twice and decide not to act against the strong public interest".

ACCC chairman Rod Sims said a bigger fine was appropriate "given the longstanding and widespread nature of the conduct, and the substantial sales and profit that was made".

The case revolved around Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache products.

The original ruling ordered that they be removed from retail shelves and packets amended.

Nurofen denied it deliberately deceived consumers and said it had cooperated with the ACCC throughout.

In Australia, Reckitt Benckiser markets and supplies a range of consumer health and household brands, including Nurofen, Mortein, Clearasil, Finish, Airwick and Gaviscon.

Explore further: Australia challenges 'misleading' Nurofen painkiller

Related Stories

Australia challenges 'misleading' Nurofen painkiller

March 5, 2015
Australia's consumer watchdog Thursday launched court action against drug giant Reckitt Benckiser, alleging false or misleading claims about its popular painkiller Nurofen.

Australia court: UK company misled consumers over painkiller

December 14, 2015
An Australian court ordered a British consumer goods company on Monday to remove several versions of a popular painkiller from stores in Australia after ruling that the company misled consumers about the products' effectiveness.

British watchdog probes Nurofen adverts

December 15, 2015
Britain's advertising watchdog said Tuesday it was investigating a TV advert for Nurofen after some versions of the painkiller were removed from shelves in Australia over misleading claims.

Painkiller recalled in Britain after suspected sabotage

August 27, 2011
The makers of painkiller Nurofen Plus have recalled the tablets in Britain after anti-psychotic and epilepsy drugs were found to have been placed in packets in acts of suspected sabotage.

Man held in Britain over contamination of painkillers

September 23, 2011
British police arrested a man on Friday after anti-psychotic and epilepsy drugs were placed in packets of the painkiller Nurofen Plus, Scotland Yard said.

Ibuprofen-codeine misuse a health risk

September 18, 2013
(Medical Xpress)—Researchers have recommended that drugs combining codeine and other pain killers, such as paracetamol or ibuprofen, be restricted to prescription-only following reports of misuse and fatalities.

Recommended for you

Students more likely to eat school breakfast when given extra time, new study finds

August 18, 2018
Primary school students are more likely to eat a nutritional breakfast when given 10 extra minutes to do so, according to a new study by researchers at Virginia Tech and Georgia Southern University.

Like shark attack and the lottery, unconscious bias influences cancer screening

August 17, 2018
What do shark attack, the lottery and ovarian cancer screening having in common? It turns out our judgments about these things are all influenced by unconscious bias.

US approves first generic competitor to Mylan's EpiPen

August 16, 2018
US regulators Thursday approved the first generic alternative for the EpiPen, a life-saving emergency allergy medicine, two years after soaring prices for the original version owned by Mylan stoked controversy.

Phantom odors: One American in 15 smells odors that aren't there, study finds

August 16, 2018
Imagine the foul smell of an ash tray or burning hair. Now imagine if these kinds of smells were present in your life, but without a source. A new study finds that 1 in 15 Americans (or 6.5 percent) over the age of 40 experiences ...

US drug overdose deaths surge amid fentanyl scourge

August 16, 2018
US drug overdose deaths surged to nearly 72,000 last year, as addicts increasingly turn to extremely powerful synthetic opioid fentanyl as the supply of prescription painkillers has tightened.

Parental life span predicts daughters living to 90 without chronic disease or disability

August 15, 2018
Researchers at the University of California San Diego School of Medicine report that women whose mothers lived to at least age 90 were more likely to also live to 90, free of serious diseases and disabilities.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.